SCHEMBL13664461

SCHEMBL13664461

COOCCCCNCC1OC(n2cnc3c(N)ncnc32)[C@@H]2OC(C)(C)O[C@H]12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PI4KA P42356 2/20 0.62
PI4K2B Q8TCG2 2/20 0.62
PI4K2A Q9BTU6 2/20 0.62
PI4KB Q9UBF8 2/20 0.62
RXFP1 Q9HBX9 1/20 0.58
P2RX3 P56373 3/20 0.53
P2RX1 P51575 2/20 0.53
P2RX4 Q99571 2/20 0.53
AMD1 P17707 3/20 0.53
DOT1L Q8TEK3 2/20 0.45
GAA P10253 1/20 0.45
PRMT7 Q9NVM4 1/20 0.43
EHMT1 Q9H9B1 1/20 0.42
DPP4 P27487 1/20 0.42
MEN1 O00255 1/20 0.42
SLC28A1 O00337 1/20 0.42
MAP3K7 O43318 1/20 0.42
SLC28A2 O43868 1/20 0.42
GAPDH P04406 1/20 0.42
ADORA3 P0DMS8 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17108373 0.88 PI4KA (0.69) PI4KAPI4K2BPI4K2API4KBRXFP1
SCHEMBL17773142 0.88 PI4KA (0.69) PI4KAPI4K2BPI4K2API4KBRXFP1
SCHEMBL9970657 0.87 PI4KA (0.63) PI4KAPI4K2BPI4K2API4KBRXFP1
SCHEMBL9940959 0.87 PI4KA (0.63) PI4KAPI4K2BPI4K2API4KBRXFP1
SCHEMBL17108376 0.86 PI4KA (0.62) PI4KAPI4K2BPI4K2API4KBRXFP1
SCHEMBL13662859 0.86 PI4KA (0.64) PI4KAPI4K2BPI4K2API4KBRXFP1
SCHEMBL803939 0.86 PI4KA (0.71) PI4KAPI4K2BPI4K2API4KBRXFP1
SCHEMBL14703568 0.86 PI4KA (0.71) PI4KAPI4K2BPI4K2API4KBRXFP1
SCHEMBL14703570 0.86 PI4KA (0.71) PI4KAPI4K2BPI4K2API4KBRXFP1
SCHEMBL15395521 0.86 PI4KA (0.71) PI4KAPI4K2BPI4K2API4KBRXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090263879-A1 Immunoassay for specific determination of S-adenosylmethionine and analogs thereof in biological samples HAO, XIUJUAN 2009-10-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090263879-A1 Immunoassay for specific determination of S-adenosylmethionine and analogs thereof in biological samples AHCY, MAT2A, MAT1A PI4KA 4647/4885PI4K2B 4514/4885PI4K2A 4571/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.